Exposure to Environmental Chemicals in Breast Milk and Infants: Pathways and Health Risks
Contents
Chair(s)
Dr. Judy S. LaKind
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Catonsville, MD, USA.
Dr. Shanshan Yin
Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
Speaker(s)
Mr. Christopher W Greene
Health Risk Assessment Unit, Minnesota Department of Health, St. Paul, MN, USA.
Topic: A toxicokinetic model to simulate bioaccumulative PFAS levels in serum and breast milk
Related Article：A revised and improved toxicokinetic model to simulate serum concentrations of bioaccumulative PFAS
Topic: A toxicokinetic model to simulate bioaccumulative PFAS levels in serum and breast milk
Related Article：A revised and improved toxicokinetic model to simulate serum concentrations of bioaccumulative PFAS
Dr. Kristine Klos
Health Risk Assessment Unit, Minnesota Department of Health, St. Paul, MN, USA.
Topic: Good News: PFAS is Not a Significant Exposure Risk in Infant Formula
Related Article：Per- and polyfluoroalkyl substances (PFAS) in powdered infant formula: potential exposures and health risks
Topic: Good News: PFAS is Not a Significant Exposure Risk in Infant Formula
Related Article：Per- and polyfluoroalkyl substances (PFAS) in powdered infant formula: potential exposures and health risks
Dr. Yu Gao
Department of Environmental Health, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Topic: Health Risks for Infants Exposed to Per- and Polyfluoroalkyl Substances Through Breast Milk: Findings from the Laizhou Wan Birth Cohort Study
Topic: Health Risks for Infants Exposed to Per- and Polyfluoroalkyl Substances Through Breast Milk: Findings from the Laizhou Wan Birth Cohort Study
Dr. Hongxiu Liu
Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Topic: Exposure Levels of PFAS in Newborns and Their Associations with Autism-like Symptoms in Children
Topic: Exposure Levels of PFAS in Newborns and Their Associations with Autism-like Symptoms in Children
Programme
Programme
- Time
- Speakers
- Topics
- 9:00pm-9:10pm (Beijing, China)
9:00am-9:10am(MD, USA)
- Dr. Judy S. LaKind
Dr. Shanshan Yin
- Introduction – A brief overview on this topic and journal introduction
- 9:10pm-9:25pm (Beijing, China)
9:10am-9:25am(MD, USA)
- Dr. Christopher W Greene
- A toxicokinetic model to simulate bioaccumulative PFAS levels in serum and breast milk.
- 9:25pm-9:40pm (Beijing, China)
9:25am-9:40am(MD, USA)
- Dr. Kris Klos
- Good News: PFAS is Not a Significant Exposure Risk in Infant Formula
- 9:40pm-09:55pm (Beijing, China)
9:40am-09:55am(MD, USA)
- Dr. Yu Gao
- Health Risks for Infants Exposed to Per- and Polyfluoroalkyl Substances Through Breast Milk: Findings from the Laizhou Wan Birth Cohort Study
- 09:55pm-10:10pm (Beijing, China)
09:55am-10:10am(MD, USA)
- Dr. Hongxiu Liu
- Exposure Levels of PFAS in Newborns and Their Associations with Autism-like Symptoms in Children
- 10:10pm-10:30pm (Beijing, China)
10:10am-10:30am(MD, USA)
- Dr. Shanshan Yin
(Q&A session，All)
- A Panel Discussion (Q&A session)
- 10:31pm-10:40pm(Beijing, China)
10:31am-10:40am(MD, USA)
- Dr. Judy S. LaKind
- Summary and Acknowledgement
